Last reviewed · How we verify

NCT07141537: CaBooM

Caloric Balance Markers Study

Recruiting now Last updated 3 September 2025
What this trial tests

trial in Metabolism in 400 participants. Currently enrolling.

Timeline
27 August 2025
Primary endpoint
31 August 2033
31 August 2033

Quick facts

Lead sponsorInstitute for Systems Biology
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment400
Start date27 August 2025
Primary completion31 August 2033
Estimated completion31 August 2033
Sites1 location across United States

Conditions studied

Sponsor

Institute for Systems Biology

Who can join

18 and older, any sex, with Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolism

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07141537.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing